Genetic polymorphisms in lung disease: bandwagon or breakthrough?

AUTOR(ES)

Iannuzzi, Michael C

FONTE

BioMed Central

RESUMO

The study of genetic polymorphisms has touched every aspect of pulmonary and critical care medicine. We review recent progress made using genetic polymorphisms to define pathophysiology, to identify persons at risk for pulmonary disease and to predict treatment response. Several pitfalls are commonly encountered in studying genetic polymorphisms, and this article points out criteria that should be applied to design high-quality genetic polymorphism studies.

Documentos Relacionados

• Growth factors in lung development and disease: friends or foe?
• The History of a Genetic Disease: Duchenne Muscular Dystrophy or Meryon's Disease
• The history of a genetic disease: Duchenne muscular dystrophy or Meryon's disease
• LRP in Alzheimer’s disease: friend or foe?
• New perspectives on basic mechanisms in lung disease: Introduction